Taysha Gene Therapies Stock Market Value
| TSHA Stock | USD 4.66 0.18 4.02% |
| Symbol | Taysha |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taysha Gene. If investors know Taysha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Taysha Gene assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.33) | Revenue Per Share | Quarterly Revenue Growth 0.786 | Return On Assets | Return On Equity |
The market value of Taysha Gene Therapies is measured differently than its book value, which is the value of Taysha that is recorded on the company's balance sheet. Investors also form their own opinion of Taysha Gene's value that differs from its market value or its book value, called intrinsic value, which is Taysha Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taysha Gene's market value can be influenced by many factors that don't directly affect Taysha Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taysha Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taysha Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Taysha Gene's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Taysha Gene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Taysha Gene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Taysha Gene.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Taysha Gene on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Taysha Gene Therapies or generate 0.0% return on investment in Taysha Gene over 90 days. Taysha Gene is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-ba... More
Taysha Gene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Taysha Gene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Taysha Gene Therapies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.48 | |||
| Information Ratio | 0.0619 | |||
| Maximum Drawdown | 21.14 | |||
| Value At Risk | (6.94) | |||
| Potential Upside | 7.92 |
Taysha Gene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taysha Gene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Taysha Gene's standard deviation. In reality, there are many statistical measures that can use Taysha Gene historical prices to predict the future Taysha Gene's volatility.| Risk Adjusted Performance | 0.0727 | |||
| Jensen Alpha | 0.3688 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.0636 | |||
| Treynor Ratio | (1.99) |
Taysha Gene February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0727 | |||
| Market Risk Adjusted Performance | (1.98) | |||
| Mean Deviation | 3.58 | |||
| Semi Deviation | 4.15 | |||
| Downside Deviation | 4.48 | |||
| Coefficient Of Variation | 1259.77 | |||
| Standard Deviation | 4.61 | |||
| Variance | 21.27 | |||
| Information Ratio | 0.0619 | |||
| Jensen Alpha | 0.3688 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.0636 | |||
| Treynor Ratio | (1.99) | |||
| Maximum Drawdown | 21.14 | |||
| Value At Risk | (6.94) | |||
| Potential Upside | 7.92 | |||
| Downside Variance | 20.11 | |||
| Semi Variance | 17.22 | |||
| Expected Short fall | (3.73) | |||
| Skewness | 0.2762 | |||
| Kurtosis | 0.06 |
Taysha Gene Therapies Backtested Returns
Taysha Gene appears to be moderately volatile, given 3 months investment horizon. Taysha Gene Therapies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0675, which indicates the firm had a 0.0675 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Taysha Gene Therapies, which you can use to evaluate the volatility of the company. Please review Taysha Gene's Semi Deviation of 4.15, risk adjusted performance of 0.0727, and Coefficient Of Variation of 1259.77 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Taysha Gene holds a performance score of 5. The entity has a beta of -0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Taysha Gene are expected to decrease at a much lower rate. During the bear market, Taysha Gene is likely to outperform the market. Please check Taysha Gene's downside variance, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Taysha Gene's existing price patterns will revert.
Auto-correlation | -0.81 |
Excellent reverse predictability
Taysha Gene Therapies has excellent reverse predictability. Overlapping area represents the amount of predictability between Taysha Gene time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Taysha Gene Therapies price movement. The serial correlation of -0.81 indicates that around 81.0% of current Taysha Gene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.81 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Taysha Gene Therapies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taysha Gene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taysha Gene Therapies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taysha Gene Therapies Stock:Check out Taysha Gene Correlation, Taysha Gene Volatility and Taysha Gene Performance module to complement your research on Taysha Gene. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Taysha Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.